US Stock MarketDetailed Quotes
ATLEW ARTELO BIOSCIENCES INC C/WTS 14/10/2025(TO PUR COM)
- 0.001
- 0.0000.00%
15min DelayClose Aug 13 16:00 ET
0Market Cap0.00P/E (TTM)
0.000High0.000Low0Volume0.000Open0.001Pre Close0.00Turnover0.00%Turnover Ratio0.00P/E (Static)0Shares0.05052wk High0.00P/B0Float Cap0.00052wk Low--Dividend TTM0Shs Float0.050Historical High--Div YieldTTM0.00%Amplitude0.000Historical Low--Avg Price1Lot Size
About ARTELO BIOSCIENCES INC C/WTS 14/10/2025(TO PUR COM) Company
Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.
Company Profile
SymbolATLEW
Company NameARTELO BIOSCIENCES INC C/WTS 14/10/2025(TO PUR COM)
Listing DateJun 21, 2019
Founded2011
CEOMr. Gregory D. Gorgas
MarketPink Market
Employees6
Fiscal Year Ends12-31
Address505 Lomas Santa Fe,Suite 160
CitySolana Beach
ProvinceCalifornia
CountryUnited States of America
Zip Code92075
Phone1-858-925-7049
Websitehttp://www.artelobio.com
Company Executives
- Name
- Position
- Salary
- Gregory D. Gorgas
- Director, President, Chief Executive Officer, Secretary, Chief Financial Officer, Principal Accounting Officer and Treasurer
- 654.83K
- Connie L. Matsui
- Chairman of the Board
- 69.54K
- Dr. R. Martin Emanuele, PhD
- Independent Director
- 37.04K
- Tamara A. Favorito
- Independent Director
- 48.04K
- Steven Kelly
- Independent Director
- 52.54K
- Dr. Douglas Blayney, M.D.
- Independent Director
- 41.04K
- Dr. Gregory R. Reyes, M.D.,PhD
- Independent Director
- 37.04K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data